Ignite Creation Date:
2025-12-24 @ 11:42 PM
Ignite Modification Date:
2026-02-23 @ 4:19 AM
Study NCT ID:
NCT02303951
Status:
TERMINATED
Last Update Posted:
2021-02-03
First Post:
2014-11-13
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Neoadjuvant Vemurafenib + Cobimetinib + Atezolizumab in Melanoma: NEO-VC
Sponsor:
University Hospital Tuebingen
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Malignant Melanoma | View |
Keywords: